Document is current
Any future updates will be listed below
-
Authors
Jung, Wonyoung
Hubbard, Rebecca A.
Smith, Amanda M.
Ko, Kyunga
Huang, Anran
Wang, Jessica
Isaacs, Jordan M.
Zhang, Liyong
Liu, Peter P.
Chen, Zhen
Shah, Payal D.
Mintzer, David
Bhattacharya, Saveri
Knollman, Hayley M.
Clark, Amy S.
Koropeckyj-Cox, Daniel
Messinger, Melissa
Wilcox, Nicholas S.
Xia, Congying
Narayan, Vivek
Upshaw, Jenica N.
Armenian, Saro H.
Ky, Bonnie
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04023110 at ClinicalTrials.govDocuments that mention this clinical trial
Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial
https://doi.org/10.1007/s10549-025-07636-3
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 HL118018)
American Heart Association (849569)
American Heart Association Transformational Project Award
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 4 February 2025
First Online: 2 April 2025
Declarations
:
: The authors declare no competing interests.
: The study was approved by the University of Pennsylvania’s Institutional Review Board and conformed to the Declaration of Helsinki standards.
: All participants provided written informed consent.
: Not applicable.
